Actualisation sur l’hypoparathyroïdie : un peu de théorie, beaucoup de pratique: Update on hypoparathyroidism: a little theory, a lot of practice

Ann Endocrinol (Paris). 2017 Oct:78 Suppl 1:S1-S10. doi: 10.1016/S0003-4266(17)30920-4.
[Article in French]

Abstract

Parathormone (PTH), produced by parathyroid glands, is the main regulator of calcium homeostasis. Hypoparathyroidism (hypoPT), due to decrease of PTH production, is a rare disease. Symptoms are multiple, altering function of several organs and leading to a decrease of quality of life. Acquired etiologies, including thyroïdectomy, the main cause of hypoPT, can be distinguished from congenital etiologies, including genetic defects. HypoPT, which is classically treated by supplementation by calcium and active vitamin D, can now be treated by recombinant injection in certain indications as a poor control under classical therapy. Here are summarized current knowledge on etiologies, epidemiology, clinical manifestations and management of hypoPT.

Keywords: Hypocalcemia; Hypocalcémie; Hypoparathyroidism; Hypoparathyroïdie; Parathormone; Vitamine D.

Publication types

  • Review

MeSH terms

  • Calcium / metabolism
  • Diagnosis, Differential
  • Diagnostic Techniques, Endocrine
  • Endocrinologists / trends
  • Genetic Diseases, Inborn / diagnosis
  • Genetic Diseases, Inborn / epidemiology
  • Genetic Diseases, Inborn / therapy
  • Humans
  • Hypoparathyroidism* / diagnosis
  • Hypoparathyroidism* / epidemiology
  • Hypoparathyroidism* / etiology
  • Hypoparathyroidism* / therapy
  • Practice Patterns, Physicians' / trends
  • Receptors, Calcium-Sensing / genetics
  • Receptors, Calcium-Sensing / metabolism

Substances

  • CASR protein, human
  • Receptors, Calcium-Sensing
  • Calcium